Jan 27 2010
Invatec, a comprehensive innovator of interventional products, today
launched its latest self-expanding peripheral stent system, Maris Plus
in new 6, 7 and 8mm diameters, ideal for interventions involving the
superficial femoral arteries (SFA). The 9, 10 and 12mm diameters of the
stent are already marketed for the iliac artery.
“It was our goal to offer dedicated stent geometries to respond to the
different needs of the iliac and SFA arteries. With the Maris Plus, we
have created a stent with an overlap region that allows two stents to
act like one in the femoral artery”
The Maris Plus stent features an exclusive cell design at the stent
ends. This allows physicians to place several stents in series without
stiffening the artery in the overlap region. The Maris Plus becomes the
sixth stent platform now marketed by Invatec for the treatment of
Peripheral Arterial Disease (PAD), greatly optimising visibility,
flexibility and ease of use for the physician.
“It was our goal to offer dedicated stent geometries to respond to the
different needs of the iliac and SFA arteries. With the Maris Plus, we
have created a stent with an overlap region that allows two stents to
act like one in the femoral artery,” said Stefan Widensohler and Andrea
Venturelli, co-founders of Invatec. The distinct design provides
excellent flexibility, fracture resistance, and tailored deployment.
Additionally, larger and fully integrated tantalum markers greatly
enhance visibility for the physician.
Artificial cilia system monitors mucus conditions in human airways